Business
Teva Pharmaceutical Industries develops and markets generic and branded medicines.
Teva Pharmaceutical Industries: Revenue grew 4.3% to $17.258B from $16.544B. The company moved from a net loss of $1.639B to net income of $1.41B. Free cash flow grew 53.3% to $1.148B from $749M. Operating margin expanded 1433 bps to 12.50%. Teva Pharmaceutical Industries's annual comparison also shows stock compensation grew faster than revenue; inventory grew faster than revenue; the balance-sheet screen falls in the distress range and requires business-model context.
The read at a glance✓ Audited against SEC data
- Growth — Revenue grew 4.3%OK
- Profitability — The company moved from a net loss of $1.639B to net income of $1.41BOK
- Cash flow — Free cash flow grew 53.3% to $1.148B from $749MOK
- Margins — Operating margin expanded 1433 bps to 12.50%OK
- Accounting — Distress-range screen needs contextWatch
- Insiders — 1 purchases and 38 salesOK
Where the revenue comes from
Fiscal 2025, as TEVA PHARMACEUTICAL INDUSTRIES LTD reports it. History and quarterly detail are in the app.
- United States$9.2B
- Europe$5.0B
- International Markets$2.2B
- Other Activities$870.0M
Leadership changes
From TEVA PHARMACEUTICAL INDUSTRIES LTD's own filings, the day they're filed.
- Matthew Shields · President · appointmenteff. 2024-06-03
- Christine Fox · President · appointment
- S. Commercial · President · appointment
Latest filings
- 8-K · Company announcement2026-09-03
- 8-K · Company announcement2026-09-03
- 10-Q · Quarterly report2026-07-29
- 8-K · Company announcement2026-07-29
- 8-K · Company announcement2026-05-28
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about TEVA PHARMACEUTICAL INDUSTRIES LTD, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.